Gülten Oskay-Özcelik

Author

Also Known As

C. Lorenz-Schlüter, Carolin Nestle-Krämling, G Oskay-Özcelik, G Öskay-Özcelik, G. Oskay-Özcelik, Gülten Oskay-Ozcelik, Gülten Oskay-Özcelik, Mustafa Deryal, Tanja Neunhöffer

Publications

509

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Ecologic Institute Ludwig-Maximilians-Universität München KU Leuven Institute of Oncology Prof. Dr. Ion Chiricuta

About

Gülten Oskay-Özcelik is an author at Charité - Universitätsmedizin Berlin specializing in oncology, medicine, and gynecology oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	204
2	Family Medicine	2	2	119
3	Nursing	1	1	91
4	Public Health	1	1	28
5	Geriatrics	1	1	13

Gülten Oskay-Özcelik

Publications

270

Citations

H-Index

Page 1

	Year	Citations
Breast cancer patients' expectations in respect of the physician–patient relationship and treatment management results of a survey of 617 patients Gülten Oskay-Özcelik, Walter Lehmacher, Dominique Könsgen, Annals of Oncology NursingFamily MedicinePatient ExperienceBreast Cancer PatientsMedicine	2007	91
Biweekly pegylated liposomal doxorubicin in patients with relapsed ovarian cancer: results of a multicenter phase-II trial Jalid Sehouli, Gülten Oskay-Özcelik, Jan Felix Kuhne, Annals of Oncology Multicenter Phase-ii TrialMedicineMetronomic TherapyGynecologyLiposomal Doxorubicin	2006	30
A survey of treatment approaches of malignant ascites in Germany and Austria C. Jehn, S. Küpferling, Gülten Oskay-Özcelik, Supportive Care in Cancer Surgical OncologyMedicineSurgeryOncologyTreatment Approaches	2014	29
Expression III: patients’ expectations and preferences regarding physician–patient relationship and clinical management—results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries Gülten Oskay-Özcelik, Sara Alavi, Rolf Richter, Annals of Oncology Family MedicineMedicineReproductive HealthGynecologyPatient-reported Outcome	2018	28
Expectations and preferences of patients with primary and relapsed ovarian cancer to maintenance therapy: A NOGGO/ENGOT-ov22 and GCIG survey (Expression IV) Irena Rohr, Sara Alavi, Rolf Richter, International Journal of Gynecological Cancer	2020	17
A prospective multicenter study of treosulfan in elderly patients with recurrent ovarian cancer: results of a planned safety analysis Sven� Mahner, Gülten Oskay-Özcelik, Elke Heidrich-Lorsbach, Journal of Cancer Research and Clinical Oncology	2012	14
Influence of migrant background on patient preference and expectations in breast and gynecological malignancies (NOGGO-expression V study): results of a prospective multicentre study in 606 patients in Germany Desislava Dimitrova, B Naghavi, Rolf Richter, BMC Cancer	2021	14
First patient treated with a re-challenge of catumaxomab in recurrent malignant ascites: a case report Klaus Pietzner, Michael Jäger, A. Schoberth, Medical Oncology Surgical OncologyMedicineRecurrent Malignant AscitesPathologyOncology	2011	13
Participation of elderly gynecological cancer patients in clinical trials Katharina Prieske, Fabian Trillsch, Gülten Oskay-Özcelik, Archives of Gynecology and Obstetrics Geriatric OncologyGeriatricsMedicineCancer ManagementClinical Trials	2018	13
Bevacizumab in heavily pre-treated and platinum resistant ovarian cancer: a retrospective study of the North-Eastern German Society of Gynaecologic Oncology (NOGGO) Ovarian Cancer Study Group. Klaus Pietzner, Rolf Richter, Radoslav Chekerov, PubMed	2011	11

Page 1